- AMA-M2 (Mitochondrial) (1)
- AMA
- Anti Nuclear Antibody (ANA) By IFA (HEP-2) (1)
- ANA IFA
- Anti Smooth Muscle Antibody (ASMA) By IFA (1)
- ASMA
- Liver Kidney Microsomal (LKM) Antibody By EIA (1)
- Anti LKM
Autoimmune Hepatitis Panel with AMA-M2 – Comprehensive Assessment for Autoimmune Liver Conditions
If you are concerned about autoimmune liver conditions, the Autoimmune Hepatitis Panel with AMA-M2 is a comprehensive diagnostic test designed to evaluate specific antibodies associated with autoimmune hepatitis and other related liver disorders. This panel provides crucial insights to aid in the accurate diagnosis and appropriate management of autoimmune liver conditions.
The panel includes the assessment of the following antibodies:
AMA-M2 (Mitochondrial Antibody): This test detects antibodies against mitochondrial antigens, which are indicative of primary biliary cholangitis (PBC), a chronic autoimmune liver disease affecting the small bile ducts.
Anti-Nuclear Antibody (ANA) By IFA (HEP-2): This test detects antibodies that target various components within the cell nucleus and is essential for assessing autoimmune diseases, including autoimmune hepatitis.
Anti-Smooth Muscle Antibody (ASMA) By IFA: The presence of anti-smooth muscle antibodies indicates autoimmune hepatitis, an inflammatory condition that affects the liver.
Liver Kidney Microsomal (LKM) Antibody By EIA: This test identifies antibodies against liver and kidney microsomes, which are associated with autoimmune hepatitis type 2.
The Autoimmune Hepatitis Panel with AMA-M2 is an invaluable tool in the early detection and differentiation of autoimmune liver disorders, allowing for timely and targeted therapeutic interventions. Early diagnosis and appropriate management are essential to prevent disease progression and preserve liver function.
Our experienced medical team ensures accurate and reliable results, guiding you towards the most suitable treatment plan based on your specific condition.
Take control of your liver health with the Autoimmune Hepatitis Panel with AMA-M2, a crucial step towards better management of autoimmune liver conditions.